Ignite Creation Date:
2025-12-25 @ 3:46 AM
Ignite Modification Date:
2026-01-10 @ 12:04 AM
Study NCT ID:
NCT00590902
Status:
COMPLETED
Last Update Posted:
2023-10-16
First Post:
2007-12-26
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Ph II OSI-774 (Erlotinib,Tarceva) In Advanced Bronchioloalveolar Cell Lung Cancer
Sponsor:
Organization: